2023 Year in review: Early breast cancer by Guilherme Nader-Marta, Ann H. Partridge

Get full text

Immune thrombocytopenia and autoimmune thyroid disease: a controversial overlap by Guilherme Nader Marta, Fernando Peixoto Ferraz de Campos

Get full text

Central nervous system metastases of lung adenocarcinoma harboring EGFR-activating mutations: survival results from a multidisciplinary approach, including EGFR-TKIs by Guilherme Harada, Renata Rodrigues da Cunha Colombo Bonadio, Guilherme Nader Marta, Debora Zachello Recchimuzzi, Gilberto de Castro

Get full text

Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment by Guilherme Nader-Marta, Chiara Molinelli, Véronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada

Get full text

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma by Guilherme Nader Marta, Leonardo G. da Fonseca, Maria Ignez Braghiroli, Fernando Moura, Paulo M. Hoff, Jorge Sabbaga

Get full text

Treatment priorities in oncology: do we want to live longer or better? by Guilherme Nader Marta, Luís G. Del Nero, Gustavo Nader Marta, Andrea Mangabeira, Gabriela Critchi, Maria J. Kovács, João Luis Fernandes da Silva, Everardo D. Saad

Get full text

Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population by Pedro Isaacsson Velho, Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, Carlos Dzik

Get full text

First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in pha... by Martine Piccart-Gebhart, Emanuela Romano, Christos Sotiriou, Marianne Paesmans, Ligia Craciun, Denis Larsimont, Roberto Salgado, Elisa Agostinetto, Laurence Buisseret, Isabelle Veys, Alex de Caluwé, Philip Poortmans, Andrea Gombos, Guilherme Nader Marta, Zoe Denis, Stylianos Drisis, Christophe Vandekerkhove, Antoine Desmet, Catherine Philippson, Dirk Van Gestel, Michail Ignatiadis

Get full text

Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core by Gustavo Nader Marta, Tomás Y. T. de Souza, Alice R. N. de Souza e Silva, Ana Paula A. Pereira, David R. Ferreira Neto, Rie N. Asso, Fabiana A. M. Degrande, Guilherme Nader-Marta, Maurício F. da Silva, Rafael Gadia, Samir A. Hanna, Bernhard Holzner, Everardo D. Saad, Morten Aagaard Petersen

Get full text

Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109) by Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer, Michael Gnant, on behalf of the PALLAS groups and investigators

Get full text

Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0 by Rodrigo Ramella Munhoz, Clarissa Maria de Cerqueira Mathias, Guilherme Harada, Aknar Calabrich, Alberto Julius Wainstein, Andréia Cristina de Melo, Antonio Carlos Buzaid, Artur Katz, Carlos Gil Ferreira, Carlos Henrique dos Anjos, Clarissa Baldotto, Clarissa Maria de Cerqueira Mathias, Elimar Elias Gomes, Fernando Moura, Gilberto de Castro, Guilherme Harada, Guilherme Nader Marta, Gustavo dos Santos Fernandes, Luiza Dib Batista Bugiato Faria, Mariana Laloni, Paulo Marcelo Gehm Hoff, Rodrigo Ramella Munhoz, Romualdo Barroso-Sousa, Sergio Jobim de Azevedo, Vladmir Cláudio Cordeiro de Lima, William Nassib William

Get full text